Stocks
Intra-Cellular Therapies (ITCI) ROA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROA, % | ? | -58.8% | -31.6% | -58.0% | -34.0% | -19.2% | -6.52% | ||
| Changes by years, y/y, % | -15pp | +27pp | -26pp | +24pp | +15pp | -15.1% | |||
Intra-Cellular Therapies. ROA, %
Intra-Cellular Therapies. ROA, changes, pp
Intra-Cellular Therapies (ITCI) ROA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| ROA, % | ? | -20.7% | -19.2% | -14.8% | -6.38% | -6.52% | -6.52% | |
| Changes by years, y/y, % | +17pp | +14pp | +15pp | +19pp | +14pp | |||
| Changes by quarters, q/q, % | +4pp | +1pp | +4pp | +8pp | 0pp | |||
